I only called it a corporate update because that was what was on the title slide of the presentation version I linked to. Looks like from slide 26 that the New Cardio/Renal IND is still on track for Q1 2017. Did anyone else see anything new in these slides from today? Also, here is the link to the Zenith presentation from today.